23.07.2024 - 25.07.2024Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
Temas de la conferencia Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing companies entering into the ADC space and tackling toxicity, there is ever-increasing target and indication-competition. Considering the significant clinical setbacks witnessed in 2023, the demand to better understand the translatability of toxicities and develop more tolerable ADCs for achieving future clinical triumphs only grows stronger.
Cuota del Congreso FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4197.00,
Conference Only - Drug Developer: USD 2999.00,
FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5097.00,
Conference Only - Solution Provider: USD 3699.00
Cantacto organizador 83 Great Titchfield Street W1W 6RH London United Kingdom